Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems.
Ang LiJennifer LaSarah B MayDanielle GuffeyWilson Luiz da Costa-JúniorChristopher Ian AmosRaka BandyoEmily M MilnerKaren M KurianDaniel C R ChenNhan V DoCarolina GranadaNimrah RiazMary T BrophyVipul C ChitaliaJ Michael GazianoDavid A GarciaMarc CarrierChristopher R FlowersNeil A ZakaiNathanael R FillmorePublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
3% and 2%, respectively, in the low-risk group). The model had improved performance over the original KS and doubled the number of VTE events in the high-risk stratum. We encourage additional external validation from prospective studies.[Media: see text].